28 Jun 2017 12:41
28 June 2017
Exercise of Warrants
Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics announces that it has received notification from warrant holders to exercise warrants representing 250,000 ordinary shares of 1p each ("Ordinary Shares") in the Company at an exercise price of 32.2p per warrant for total consideration of £80,500.
Application has been made for the 250,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), which is expected to occur at 8.00 a.m. on July 3 2017. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Following Admission, and for the purposes of the Disclosure Guidance and Transparency Rules, the Company's total issued share capital will consist of 263,128,775 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the issued share capital of the Company.
For further information please contact:
Motif Bio plc | info@motifbio.com | ||
Graham Lumsden (Chief Executive Officer) | |||
Robert Dickey IV (Chief Financial Officer) | |||
Peel Hunt LLP (NOMAD & BROKER) | + 44 (0)20 7418 8900 | ||
Dr Christopher Golden | |||
Oliver Jackson | |||
Northland Capital Partners Limited (BROKER) | +44 (0)203 861 6625 | ||
Patrick Claridge/ David Hignell | |||
John Howes/ Rob Rees (Broking) | |||
Walbrook PR Ltd. (FINANCIAL PR & IR) | +44 (0) 20 7933 8780 or motifbio@walbrookpr.com | ||
Paul McManus | Mob: +44 (0)7980 541 893 | ||
Mike Wort | Mob: +44 (0)7900 608 002 | ||
MC Services AG (EUROPEAN IR) | +49 (0)89 210 2280 | ||
Raimund Gabriel | |||
MTFB.L (MTFB)